1 Purpose: To determine the effect of lens care system combinations on levels of total lipid, 2 cholesterol and cholesteryl esters extracted from three different contact lenses when used with four 3 contemporary care systems. 4
Introduction 1
The tear film consists of water, ions, proteins and lipids. Tear film lipids are produced by 2 the meibomian glands, which are specialized holocrine glands that line both the upper and lower 3 eyelids. 1 Meibomian gland fluid consists of both polar and non-polar molecules and includes 4 steroids, glycerides, saturated and unsaturated fatty acids, fatty acid polar esters and polar lipids. 2 5 Non-polar lipids comprise the outer tear film layer and overly the polar lipids, which act as the 6 intermediate phase between the aqueous layer and non-polar lipid layer and aid in tear film 7 stability. 3 Disorders of the meibomian glands or lipid layer of the tear film can lead to numerous 8 ocular disorders, with dry eye being the major complication reported. 4 9
The impact of tear film lipids on contact lens wear has been studied for several decades. 5-10 13 Lipid deposition may impact contact lens comfort, clarity of vision and potentially initiate an 11 inflammatory state, secondary to lipid degradation. 12, 14 There has been some speculation that 12 oxidation of lipids may be contributory to end of day contact lens discomfort [14] [15] [16] and lipids appear 13 to be degraded to greater amounts in overnight versus daily wear of contact lenses. 14 Longer 14 replacement periods resulted in increased lipid deposition. 17, 18 Initial studies on soft contact lens 15 lipid deposits described the appearance of "jelly bumps", "lens calculi" or "mulberry spots", which 16 were found to be principally made of cholesteryl esters. 5, 19, 20 The role of lipid deposits on the 17 health of the ocular surface has also been investigated, as more solution induced corneal staining 18 was observed in patients with greater amounts of lipid deposits. 21 19 compared with conventional hydrogel materials. [22] [23] [24] As a result, silicone hydrogel lenses are more 23 hydrophobic, 22, 24-26 and more prone to lipid deposition. Deposition of total lipid, cholesterol, 24 cholesterol esters and triglycerides/phospholipids on contact lenses has been investigated. 27 A 25 silicone hydrogel material (balafilcon A) deposited higher levels of lipid when compared to a 26 hydrogel material (etafilcon A) after 10 hours of daily disposable or 7 days of extended wear, 27 demonstrating that lipid deposition occurs relatively rapidly. 27 A full understanding of the total 28 lipid deposited on worn lenses has been complicated by the large variation in reported levels of 29 deposition between authors, using different quantification techniques. Enzymatic sulpho-phospho-30 vanillin and enzymatic oxidation were used to demonstrate higher levels of cholesterol deposition 31 (20-30 μg/lens) on worn lenses when compared with other lipids. 28 In that same study, the levels 32 of total lipid deposition was 33-42 μg/lens. 28 33 Nash and colleagues, using a fluorescent enzymatic assay, also showed significant differences in 34 lipid deposition on worn silicone hydrogel materials, with maximum lipid deposition being 35 approximately 4 μg/lens. 12 Both of these studies are in contrast to earlier studies, which utilized 36 high performance liquid chromatography (HPLC) to quantify up to 600 μg/lens of certain lipids, 37 although the authors have recently quantified 40 μg/lens of lipid deposition on lenses and 38 suggested this amount may be more accurate. 7, 8, 11 39 Recent studies have investigated the impact of care solutions on removal of lipids deposited 40 on contact lenses. One study, that investigated the deposition and removal of cholesterol and 41 dipalmitoylphosphatidylcholine (DPPC) using commercial solutions or borate buffered saline, 42 coupled with simulated rubbing, reported that only a small amount of cholesterol and no DPPC 43 was removed by these solutions. 10 Cheung et al. 29 used atomic force microscopy to visualize the 44 deposits on the surface of lenses soaked in artificial tear solution and indicated that after cleaning 45 contact lenses using a hydrogen peroxide or polyhexamethylene biguanide solution, only trace 46 visible amounts of the tear fluid components remained on the lens surface. 29 47
The design of modern contact lens care solutions is complicated by the multiplicity of 48 roles that need to be performed by a single solution. A single solution is expected to clean, 49 condition and disinfect worn contact lenses, and also be compatible with the ocular surface. 50 Furthermore, the majority of lenses are marketed as being compatible and appropriate for all soft 51 contact lens types. However, there remains only a small amount of data from human studies 52 demonstrating the effect of lens/solution combinations on the deposition of lipids. [30] [31] [32] Considering 53 the potential importance of contact lens lipid deposits on vision and comfort, information on the 54 degree to which modern materials deposit when used with contemporary care solutions is needed. 55
The aim of this ex vivo study was to determine the effect of lens care system combinations 56 on levels of total lipid, cholesterol and cholesteryl esters extracted from three different contact 57 lenses when used with four contemporary care systems. 58 Florida). The properties of the lenses used in this study are presented in Table 1 . A total of four 74 contact lens care solutions were investigated in this study. Detailed properties of the four solutions 75 investigated are presented in Table 2 . 76
Materials and Methods
Each participant received a product information form which had instructions on the proper use of 77 the dispensed solutions as per each manufacturer's instructions. For the preserved solutions, 78 participants were instructed to rub their lenses for 2-4 sec and rinse for 5 sec using RevitaLens; 79 rub their lenses for 20 sec and rinse for 10 sec using PureMoist; rub their lenses for 20 sec and 80 rinse for 5 sec using Biotrue, before placing them into lens cases for overnight soaking. When 81
ClearCare was used, no rub was required but participants were instructed to rinse their lenses for 82 5 sec when the lens was in the lens holder and then fill the lens case before overnight soaking. 83
Study Design and Wear Schedule 84
Each subject was randomly allocated to wear one of the three lens types after a washout 85 period wearing either spectacles or 1-Day ACUVUE Moist (1DAVM). Once assigned, each 86 participant utilized each of the four investigational solutions over a period of 10-14 days in a 87 randomized sequential fashion, with a minimum wear time of 8 hours per day, and 8 total days of 88 contact lens wear in that period. Between solutions, there was a washout period of at least 4 days 89 with spectacle or 1DAVM wear. 90
Subjects were masked to the lens type being used and the solutions were de-identified as 91 much as possible, while the clinical investigator(s) were masked as to the type of care solution that 92 participants used. At the end of each lens-solution wear period (contact lenses were collected at 93 scheduled visits), the clinical investigator, wearing latex-free gloves, removed the lens from the 94 participant's left eye and placed it directly in a dry 7 ml polypropylene vial. Each contact lens was 95 stored individually and the vials were sealed prior to storage at -80˚ C until analysis took place. 96
The lens-containing vials were placed in cryoboxes and subsequently in Styrofoam filled 97 completely with dry ice before shipping them to Johnson & Johnson Vision Care Inc. (Analytical 98
Research & Development, Jacksonville, Florida) for the analysis of cholesterol, cholesteryl esters 99 and total lipid amounts. Lenses collected from the participants' right eye were used for protein 100 analysis and the results from this portion of the study have been published previously. 33 
Preparation of Lipid Working Standards 110
A stock solution of cholesteryl linoleate and cholesterol was prepared in diluent (70% 111 heptane and 30% isopropanol) at 1000 µg/mL and 500 µg/mL, respectively. A series of working 112 standards with concentrations of 0.5, 1.0, 5.0, 10.0, 15.0, and 20.0 µg/mL for cholesteryl linoleate 113 and 0.25, 0.50, 2.5, 5.0, 7.5 and 10.0 µg/mL for cholesterol were prepared from the stock solution. 114
Each working standard also contained cholesteryl-2,2,3,4,4,6-d6 octadecanoate and cholesterol-115 2,2,3,4,4,6-d6 at the 2.5 µg/mL level. 116
Lipid Extraction 117
Cholesteryl esters and cholesterol were extracted from contact lenses using 118 dichloromethane in 20 mL glass scintillation vials. To each vial, contact lens, 5 mL of 119 dichloromethane and 100 µL of an internal standard solution were added. The internal standard 120 solution consisted of cholesteryl-2,2,3,4,4,6-d6 octadecanoate and cholesterol-2,2,3,4,4,6-d6 (CDN 121 Isotopes) each at the 25 µg/mL level in diluent (70% heptane and 30% isopropanol). Lenses were 122 extracted for a minimum of 16 hours at 3°C. Extracts were then transferred to a 5 mL disposable 123 glass culture tube and evaporated using a TurboVap LV Concentration Evaporator Workstation 124 (Biotage, Charlotte, NC). Dried extracts were immediately reconstituted with 1 mL of diluent and 125 carefully transferred to Thermo autosampler vials for Liquid Chromatography-Mass Spectrometry 126 analysis. When necessary, lens extracts were further diluted in order to measure the sample within 127 the range of the working standard calibration curve. Unworn lenses were used as controls and 128 specificity was demonstrated during method qualification. 129
Liquid Chromatography-Mass Spectrometry (LC-MS)
equipped with an atmospheric pressure chemical ionization (APCI) source. The LC separation 134 was performed on an Agilent Zorbax NH2 column (4.6 x 150 mm; 5 m particle size). The 135 isocratic elution method consisted of 70% heptane and 30% isopropanol with a flow rate of 1000 136 L/min. The column temperature was set at 30C and the injection volume was 25 L. Thermo Table 3 
demonstrates that higher amounts of cholesterol esters were 177 extracted from senofilcon A and galyfilcon A lenses compared to etafilcon A lenses (p<0.05). 178
There were no significant differences in the amounts of cholesteryl esters extracted from a given 179 lens type when used with the different care solutions (p>0.05). 180
Total Lipid 181 amounts of total lipids were extracted from senofilcon A and galyfilcon A lenses than etafilcon A 184
lenses (p<0.05). There were no significant differences in the amounts of total lipid extracted from 185 a given lens type when used with the various care solutions (p>0.05). The amounts of cholesterol recovered from the aforementioned in vitro study were higher than the 208 amounts of cholesterol recovered from the current ex vivo study, which could be due to the use of 209 different quantification methods employed in these two studies (radiolabelling in Tam et al. study 210 versus LC-MS technique in the current study) or the fact that one study was an in vitro study and 211 the other examined ex vivo lenses. 212
In an ex vivo study, Zhao et al. 32 investigated the use of different solutions (OPTI-FREE 213 Express, AQuify, ClearCare and OPTI-FREE RepleniSH) on the deposition and removal of 214 cholesterol from galyfilcon A and senofilcon A lenses. Between the two lenses, the greatest 215 amount of cholesterol was recovered from galyfilcon A (6.4 ± 0.2 μg/lens) materials cleaned with 216 OPTI-FREE Express, while only 2.7 ± 0.8 μg/lens was recovered from senofilcon A materials 217 using the same solution. 32 The amounts of lipid recovered in that study are in the range of the 218 amounts of cholesterol recovered in the current study using different care solutions. 32 respectively. In the current study when ClearCare was used, 4.29 ± 4.85 μg/lens and 4.75 ±2 .54 225 μg/lens of cholesterol was recovered from senofilcon A and galyfilcon A lenses respectively, 226 which is higher than the amounts found in the Nash et al. study. Use of different quantification 227 techniques could once again be the reason for the discrepancy in results between these two studies.
12
The mean range of cholesteryl esters recovered across different care solutions was 1.31-229 2.02 μg/lens, 6.43-7.19 μg/lens and 7.96-10.13 μg/lens for etafilcon A, senofilcon A and galyfilcon 230 A lenses, respectively. Total cholesterol esters deposited on etafilcon A after 7 days of extended 231 wear reported by Maissa et al. 27 was 3.39 ± 2.63 μg/lens, suggesting that there might be more 232 deposition of cholesterol esters when the lenses are worn on an extended wear basis, wherein they 233 are not subjected to cleaning using a lens care system. Pucker et al. 39 developed an enzymatic 234 method to determine ex vivo and in vitro levels of cholesterol and cholesterol esters deposition on 235 lotrafilcon B and galyfilcon A contact lenses. 39 Using this method, they determined that galyfilcon 236 A deposited 5.77 ± 1.87 μg/lens when worn with either OPTI-FREE Express or OPTI-FREE 237
RepleniSH. 238
Hatou et al. 28 studied the total amount of lipid, phospholipid and cholesterol deposited on 239 galyfilcon A, senofilcon A and asmofilcon A lens materials. There was no restriction on 240 multipurpose care solution types that could be used by the patients during the two weeks of the 241 study. Hatou et al. 28 did not find a significant difference in the amount of total lipid or cholesterol 242 deposited on the galyfilcon A or senofilcon A lenses, although the amounts of lipids reported were 243 significantly higher than what is reported in the current study, with total lipid and cholesterol being 244 estimated to be 32.9 ± 33.8 μg/lens and 26.2 ± 26.9 μg/lens for galyfilcon A and 42.1 ± 14.0 μg/lens 245 and 28.6 ± 19.4 μg/lens for senofilcon A. 28 The large difference between the two studies may be 246 due to the difference between the characteristics of the study populations, differences in care 247 solutions used and differences in the lipid extraction and recovery methods used (enzymatic and 248 colorimetric probes for Hatou et al. versus LC-MS used in the current study). 249
Using a sulfo-phospho-vanillin assay, Mochizuki et al. 40 also measured the amount of total 250 lipids extracted from contact lenses. They found that total lipid deposition was greater in the 251 polymacon group (66.3 ± 16.3 µg/lens) than in the etafilcon A group (44.1 ± 8.2 µg/lens). The 252 amount of total lipid in the current study ranged from 1.40 ± 1.01 to 2.11 ± 2.38 µg/lens on 253 etafilcon A when RevitaLens OcuTec and OPTI-FREE PureMoist care solutions were used 254 respectively, which is much lower than that reported by Mochizuki and co-workers. This 255 difference could be due to study populations or the use of different measurement methodology in 256 the studies (sulfo-phospho-vanillin assay for Mochizuki et al. versus LC-MS in the current study). 257
In conclusion, this study did not demonstrate conclusively that any of the solution/contact 258 lens combinations were superior to any of the other combinations, when the amounts of lipid 259
recovered were compared among the tested lenses. This limits the ability to make specific 260 recommendations regarding optimal lens care solution-material combinations for wearers. 
